Image pharmaphorum Editor Healthcare Bring point of care testing to the community for a preventat... The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to the community, according to a new Digital Is the proposed Data Protection and Digital Information Bill... A new Data Protection and Digital Information Bill is currently being considered by UK ministers. Market Access Upholding regulatory compliance in decentralised trials Before getting lost in the vast options a decentralised clinical trial (DCT) setup provides, sponsors considering a DCT model need to keep in mind that it is not a one-size-fits-all approac Pharma Market Access Pharma manufacturing can digitalise its way round the next c... The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis. Load more results
Healthcare Bring point of care testing to the community for a preventat... The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to the community, according to a new
Digital Is the proposed Data Protection and Digital Information Bill... A new Data Protection and Digital Information Bill is currently being considered by UK ministers.
Market Access Upholding regulatory compliance in decentralised trials Before getting lost in the vast options a decentralised clinical trial (DCT) setup provides, sponsors considering a DCT model need to keep in mind that it is not a one-size-fits-all approac
Pharma Market Access Pharma manufacturing can digitalise its way round the next c... The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
